Novel cancer‐specific epidermal growth factor receptor antibody obtained from the serum of esophageal cancer patients with long‐term survival-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Novel cancer‐specific epidermal growth factor receptor antibody obtained from the serum of esophageal cancer patients with long‐term survival

Published:2022-04-18 Issue:6 Volume:113 Page:2118-2128
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Science

Author:

Takagi‐Maeda Sayaka¹,Yajima Satoshi²,Suzuki Takashi²,Usami Katsuaki¹^ORCID,Takahashi Nobuaki³,Niwa Rinpei¹,Shimada Hideaki²⁴^ORCID

Affiliation:

1. Research and Development Division Kyowa Kirin Co., Ltd. Machida‐shi Tokyo Japan

2. Department of Surgery, School of Medicine Toho University Ota‐ku Tokyo Japan

3. Research and Development Division Kyowa Kirin Co., Ltd. Chiyoda‐ku Tokyo Japan

4. Department of Gastroenterological Surgery and Clinical Oncology Toho University Graduate School of Medicine Tokyo Japan

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.15350

Reference30 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Recent advancements in esophageal cancer treatment in Japan

3. Phase I clinical trial of adoptive transfer of expanded natural killer cells in combination with I g G 1 antibody in patients with gastric or colorectal cancer

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements in ovarian cancer immunodiagnostics and therapeutics via phage display technology;Frontiers in Immunology;2024-05-28

2. The pharmacological mechanism of β-elemene in the treatment of esophageal cancer revealed by network pharmacology and experimental verification;Scientific Reports;2023-07-27

3. Identification of glioblastoma-specific antigens expressed in patient-derived tumor cells as candidate targets for chimeric antigen receptor T cell therapy;Neuro-Oncology Advances;2022-11-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3